TLR4 polymorphisms and ageing: Implications for the pathophysiology of age-related diseases

Journal of Clinical Immunology

Volumn 29, Issue 4, 2009, Pages 406-415

  Balistreri, Carmela Rita ^a   Colonna Romano, Giuseppina ^a   Lio, Domenico ^a   Candore, Giuseppina ^a   Caruso, Calogero ^a  

^a Gruppo di Studio sull'Immunosenescenza   (Italy)

Author keywords

Ageing; Alzheimer's disease; atherosclerosis; cancer; innate immunity; longevity; SNP; TLR4

Indexed keywords

TOLL LIKE RECEPTOR 4;

ACUTE HEART INFARCTION; AGING; ALLELE; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CORONARY ARTERY DISEASE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; INNATE IMMUNITY; LONGEVITY; MICROORGANISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

AGING; ALLELES; ALZHEIMER DISEASE; CARDIOVASCULAR DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; LONGEVITY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; TOLL-LIKE RECEPTOR 4;

EID: 67651213832     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-009-9297-5     Document Type: Review

References (103)

1. G De Benedictis C Franceschi 2006 The unusual genetics of human longevity Sci Aging Knowledge Environ 2006 10 pe20 10.1126/sageke.2006.10.pe20
2. S Salvioli F Olivieri F Marchegiani M Cardelli A Santoro E Bellavista 2006 Genes, ageing and longevity in humans: problems, advantages and perspectives Free Radic Res 40 1303 1323 10.1080/10715760600917136
3. R Ostan L Bucci M Capri S Salvioli M Scurti E Pini 2008 Immunosenescence and immunogenetics of human longevity Neuroimmunomodulation 15 224 240 10.1159/000156466. doi:10.1159/000156466
4. G Candore CR Balistreri F Listì MP Grimaldi S Vasto G Colonna-Romano 2006 Immunogenetics, gender, and longevity Ann N Y Acad Sci 1089 516 537 10.1196/annals.1386.051
5. G Candore G Colonna-Romano CR Balistreri D Di Carlo MP Grimaldi F Listì 2006 Biology of longevity: role of the innate immune system Rejuvenation Res 9 143 148 10.1089/rej.2006.9.143
6. G Candore CR Balistreri G Colonna-Romano MP Grimaldi D Lio F Listi' 2008 Immunosenescence and anti-immunosenescence therapies: the case of probiotics Rejuvenation Res 11 425 432 10.1089/rej.2008.0662
7. G Pawelec A Akbar C Caruso R Solana B Grubeck-Loebenstein A Wikby 2005 Human immunosenescence: is it infectious? Immunol Rev 205 257 268 10.1111/j.0105-2896.2005.00271 (Pubitemid 40780191)
8. G Pawelec E Derhovanessian A Larbi J Strindhall A Wikby 2009 Cytomegalovirus and human immunosenescence Rev Med Virol 19 47 56 10.1002/rmv.598
9. D Aw AB Silva DB Palmer 2007 Immunosenescence: emerging challenges for an ageing population Immunology 120 435 446 10.1111/j.1365-2567.2007.02555.x
10. AL Gruver LL Hudson GD Sempowski 2007 Immunosenescence of ageing J Pathol 211 144 156 10.1002/path.2104
11. BR Troen 2003 The biology of aging Mt Sinai J Med 70 3 22 (Pubitemid 36041428)
12. C Franceschi L Motta M Motta M Malaguarnera M Capri S Vasto 2008 IMUSCE. The extreme longevity: the state of the art in Italy Exp Gerontol 43 45 52 10.1016/j.exger.2007.06.006
13. M Capri S Salvioli D Monti C Caruso G Candore S Vasto 2008 Human longevity within an evolutionary perspective: the peculiar paradigm of a post-reproductive genetics Exp Gerontol 43 53 60 10.1016/j.exger.2007.06.004
14. S Vasto G Candore CR Balistreri M Caruso G Colonna-Romano MP Grimaldi 2007 Inflammatory networks in ageing, age-related diseases and longevity Mech Ageing Dev 128 83 91 10.1016/j.mad.2006.11.015
15. KS Krabbe M Pedersen H Bruunsgaard 2004 Inflammatory mediators in the elderly Exp Gerontol 39 687 699 10.1016/j.exger.2004.01.009
16. Y Kumagai O Takeuchi S Akira 2008 Pathogen recognition by innate receptors J Infect Chemother 14 86 92 10.1007/s10156-008-0596-1
17. O Takeuchi S Akira 2009 Innate immunity to virus infection Immunol Rev 227 75 86 10.1111/j.1600-065X.2008.00737.x.
18. S Uematsu S Akira 2008 Toll-like receptors (TLRs) and their ligands Handb Exp Pharmacol 183 1 20 10.1007/978-3-540-72167-3-1
19. JM Blander 2008 Phagocytosis and antigen presentation: a partnership initiated by Toll-like receptors Ann Rheum Dis 67 Suppl 3 iii44 iii49 10.1136/ard.2008.097964
20. MG Netea FL van de Veerdonk BJ Kullberg JW Van der Meer LA Joosten 2008 The role of NLRs and TLRs in the activation of the inflammasome Expert Opin Biol Ther 8 1867 1872 10.1517/14712590802494212
21. S Richards C Watanabe L Santos A Craxton EA Clark 2008 Regulation of B-cell entry into the cell cycle Immunol Rev 224 183 200 10.1111/j.1600-065X. 2008.00652.x
22. YC Lu WC Yeh PS Ohashi 2008 LPS/TLR4 signal transduction pathway Cytokine 42 145 151 10.1016/j.cyto.2008.01.006
23. C Hashimoto KL Hudson KV Anderson 1988 The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein Cell 29 52 269 279
24. R Medzhitov P Preston-Hurlburt CA Janeway Jr 1997 A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature 388 394 397 10.1038/41131
25. MF Tsan B Gao 2004 Endogenous ligands of Toll-like receptors J Leukoc Biol 76 514 519 10.1189/jlb.0304127
26. A Zeytun JC van Velkinburgh PE Pardington RR Cary G Gupta 2007 Pathogen-specific innate immune response Adv Exp Med Biol 598 342 357 10.1007/978-0-387-71767-8-24
27. K Miyake 2007 Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors Semin Immunol 19 3 10 org/10.1016/j.smim.2006. 12.002
28. C-L Ku K Yang J Bustamante A Puel H von Bernuth OF Santos 2005 Inherited disorders of human Toll-like receptor signaling: Immunological implications Immunol Rev 203 10 20 10.1111/j.0105-2896.2005.00235.x
29. CR Balistreri G Candore G Colonna-Romano MP Grimaldi D Lio F Listì 2009 Role of TLR polymorphisms in immunosenescence T Fulop Handbook on Immunosenescence Springer Netherlands 659 670 10.1007/ 978-1-4020-9062-2-1 Balistreri CR, Candore G, Colonna-Romano G, Grimaldi MP, Lio D, Listì F, et al. Role of TLR polymorphisms in immunosenescence. In: Fulop T, editor. Handbook on Immunosenescence. Netherlands: Springer; 2009. p. 659-70. doi: 10.1007/978-1-4020-9062-2-1.
30. D van Duin AC Shaw 2007 Toll-like receptors in older adults J Am Geriatr Soc 55 1438 1444 10.1111/j.1532-5415.2007.01300.x
31. H Bruunsgaard BK Pedersen 2003 Age-related inflammatory cytokines and disease Immunol Allergy Clin North Am 23 15 39 10.1016/S0889-8561(02) 00056-5 (Pubitemid 36268302)
32. L Rink I Cakman H Kirchner 1998 Altered cytokine production in the elderly Mech Ageing Dev 102 199 209 10.1016/S0047-6374(97)00153-X
33. T Fulop A Larbi N Douziech C Fortin KP Guérard O Lesur 2004 Signal transduction and functional changes in neutrophils with aging Aging Cell 3 217 226 10.1111/j.1474-9728.2004.00110.x
34. D van Duin S Mohanty V Thomas S Ginter RR Montgomery E Fikrig 2007 Age-associated defect in human TLR-1/2 function J Immunol 178 970 975 (Pubitemid 46095170)
35. C Franceschi M Bonafè S Valensin F Olivieri M De Luca E Ottaviani 2000 Inflamm-aging. An evolutionary perspective on immunosenescence Ann N Y Acad Sci 908 244 254 10.1111/j.1749-6632.2000.tb06651.x (Pubitemid 30462008)
36. A Agrawal S Agrawal S Gupta 2007 Dendritic cells in human aging Exp Gerontol 42 421 426 0.1007/s10875-007-9127-6 (Pubitemid 46561174)
37. Rea IM, Candore G, Cavalloni L, Franceschi C, Colonna-Romano G, Lio D, et al. Longevity. In: Vandenbroeck K, editor. Cytokine gene polymorphisms in multifactorial conditions. Florida: CRC; 2006. p. 379-94. ISBN 9780849336195.
38. D van Duin HG Allore S Mohanty S Ginter FK Newman RB Belshe 2007 Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults J Infect Dis 195 1590 1597 10.1086/516788
39. I Smirnova A Poltorak EK Chan C McBride B Beutler 2000 Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4) Genome Biol 1 1 RESEARCH002.1 RESEARCH002.10
40. A Mushegian R Medzhitov 2001 Evolutionary perspective on innate immune recognition J Cell Biol 155 705 710 10.1083/jcb.200107040
41. B Ferwerda MB McCall S Alonso EJ Giamarellos-Bourboulis M Mouktaroudi N Izagirre 2007 TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans Proc Natl Acad Sci U S A 104 16645 16650 10.1073/pnas.0704828104
42. B Ferwerda MB McCall K Verheijen BJ Kullberg AJ van der Ven JW Van der Meer 2008 Functional consequences of toll-like receptor 4 polymorphisms Mol Med 14 346 352 10.2119/2007-00135 (Pubitemid 351785708)
43. NC Arbour E Lorenz BC Schutte J Zabner JN Kline M Jones 2000 TLR4 mutations are associated with endotoxin hyporesponsiveness in humans Nat Genet 25 187 191 10.1038/76048
44. CR Balistreri G Candore F Listì T Fazio S Gangi E Incalcaterra 2007 Role of TLR4 polymorphisms in inflammatory responses: implications for unsuccessful aging Ann N Y Acad Sci 1119 203 207 10.1196/annals.1404.003
45. S Vasto G Candore F Listì CR Balistreri G Colonna-Romano M Malavolta 2008 Inflammation, genes and zinc in Alzheimer's disease Brain Res Brain Res Rev 58 96 105 10.1016/j.brainresrev.2007.12.001
46. H Akiyama S Barger S Barnum B Bradt J Bauer GM Cole 2000 Inflammation and Alzheimer's disease Neurobiol Aging 21 383 421 10.1016/S0197-4580(00)00124-X
47. WJ Streit KR Miller KO Lopes E Njie 2008 Microglial degeneration in the aging brain-bad news for neurons? Front Biosci 13 3423 3438 10.2741/2937
48. K Fassbender S Walter S Kühl R Landmann K Ishii T Bertsch 2004 The LPS receptor (CD14) links innate immunity with Alzheimer's disease FASEB J 18 203 205 10.1096/fj.03-0364fje
49. SC Tang JD Lathia PK Selvaraj DG Jo MR Mughal A Cheng 2008 Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal Exp Neurol 213 114 121 10.1016/j.expneurol.2008.05.014
50. M Bsibsi R Ravid D Gveric JM van Noort 2002 Broad expression of Toll-like receptors in the human central nervous system J Neuropathol Exp Neurol 61 1013 1021 (Pubitemid 35278723)
51. CE Finch TE Morgan 2007 Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper Curr Alzheimer Res 4 185 189 10.2174/156720507780362254
52. G Candore CR Balistreri MP Grimaldi F Listì S Vasto M Chiappelli 2007 Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: a pharmacogenomic approach Mech Ageing Dev 128 67 75 10.1016/j.mad.2006.11.013
53. P Minoretti C Gazzaruso CD Vito E Emanuele M Bianchi E Coen 2006 Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease Neurosci Lett 391 147 149 10.1016/j.neulet. 2005.08.047
54. CR Balistreri MP Grimaldi M Chiappelli F Licastro L Castiglia F Listì 2008 Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease Curr Pharm Des 14 2672 2677 10.2174/138161208786264089
55. B Huang J Zhao H Li KL He Y Chen SH Chen 2005 Toll like receptors on tumor cells facilitate evasion of immune surveillance Cancer Res 65 5009 5014 10.1158/0008-5472.CAN-05-0784
56. MG Kelly AB Alvero R Chen DA Silasi VM Abrahams S Chan 2006 TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer Cancer Res 66 3859 10.1158/0008-5472.CAN-05-3948
57. AM De Marzo EA Platz S Sutcliffe J Xu H Grönberg CG Drake 2007 Inflammation in prostate carcinogenesis Nat Rev Cancer 7 256 269 10.1038/nrc2090
58. S Vasto G Carruba D Lio G Colonna-Romano D Di Bona G Candore 2009 Inflammation, ageing and cancer Mech Ageing Dev 130 40 45 10.1016/j.mad.2008.06. 003
59. FR Greten L Eckmann TF Greten JM Park ZW Li LJ Egan 2004 IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 285 296 10.1016/j.cell.2004.07.013
60. M Karin FR Greten 2005 NF-kappaB: linking inflammation and immunity to cancer development and progression Nat Rev Immunol 5 749 759 10.1038/nri1703
61. WW van Maren JF Jacobs IJ de Vries S Nierkens GJ Adema 2008 Toll-like receptor signalling on Tregs: to suppress or not to suppress? Immunology 124 445 452 10.1111/j.1365-2567.2008.02871.x
62. A Jemal R Siegel E Ward Y Hao J Xu T Murray 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010
63. WG Nelson AM De Marzo WB Isaacs 2003 Prostate cancer N Engl J Med 24 349 366 381 (Pubitemid 36886244)
64. G Sardana B Dowell EP Diamandis 2008 Emerging biomarkers for the diagnosis and prognosis of prostate cancer Clin Chem 54 1951 1960 10.1373/clinchem.2008.110668
65. Caruso C, Balistreri CR, Candore G, Carruba G, Colonna-Romano G, Di Bon AD, et al. Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach. Cancer Immunol Immunother. 2009. doi: 10.1007/s00262-009-0658-y.
66. SL Zheng K Augustsson-Bälter B Chang M Hedelin L Li HO Adami 2004 Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the Cancer Prostate in Sweden Study Cancer Res 64 2918 2922 10.1158/0008-5472.CAN-03-3280
67. YC Chen E Giovannucci R Lazarus P Kraft S Ketkar DJ Hunter 2005 Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer Cancer Res 65 11771 11778 10.1158/0008-5472.CAN-05-2078
68. I Cheng SJ Plummer G Casey JS Witte 2007 Toll-like receptor 4 genetic variation and advanced prostate cancer risk Cancer Epidemiol Biomarkers Prev 16 352 355 10.1158/1055-9965.EPI-06-0429
69. Balistreri CR, Caruso C, Carruba G, Miceli V, Campisi I, Lio D, Colonna-Romano G. F. Listì F,Candore G. A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implications. Curr Pharm Des. 2009. (in press).
70. A Vink DP de Kleijn G Pasterkamp 2004 Functional role for toll-like receptors in atherosclerosis and arterial remodeling Curr Opin Lipidol 15 515 521 10.1097/00041433-200410000-00004
71. G Pasterkamp JK Van Keulen DP De Kleijn 2004 Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease Eur J Clin Invest 34 328 334 10.1111/j.1365-2362.2004.01338.x
72. H Bjorkbacka 2006 Multiple roles of Toll-like receptor signaling in atherosclerosis Curr Opin Lipidol 17 527 533 (Pubitemid 44372683)
73. AE Mullick PS Tobias LK Curtiss 2006 Toll-like receptors and atherosclerosis: key contributors in disease and health? Immunol Res 34 193 209 10.1385/IR:34:3:193
74. S Frantz G Ertl J Bauersachs 2007 Mechanisms of disease: Toll-like receptors in cardiovascular disease Nat Clin Pract Cardiovasc Med 4 444 454 10.1038/ncpcardio0938
75. LL Stoll GM Denning NL Weintraub 2006 Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease Curr Pharm Des 12 4229 4245 10.2174/138161206778743501
76. S Kiechl E Lorenz M Reindl CJ Wiedermann F Oberhollenzer E Bonora 2002 Toll-like receptor 4 polymorphisms and atherogenesis N Engl J Med 347 185 192 10.1056/NEJMoa012673
77. MG Netea A Hijmans S van Wissen TJ Smilde MD Trip BJ Kullberg 2004 Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia Eur J Clin Invest 34 94 99 10.1111/j.1365-2362.2004.01303.x
78. GD Norata K Garlaschelli M Ongari S Raselli L Grigore F Benvenuto 2005 Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS J Intern Med 258 21 27 10.1111/j.1365-2796.2005.01509.x
79. R Labrum S Bevan M Sitzer M Lorenz HS Markus 2007 Toll receptor polymorphisms and carotid artery intima-media thickness Stroke 38 1179 1184 10.1161/01.STR.0000260184.85257.2b
80. JA Hernesniemi OT Raitakari M Kähönen M Juonala N Hutri-Kähönen J Marniemi 2008 Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity. The cardiovascular risk in young Finns study Atherosclerosis 198 152 159 10.1016/j.atherosclerosis.2007. 09.024
81. N Ameziane T Beillat P Verpillat S Chollet-Martin MC Aumont P Seknadji 2003 Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events Arterioscler Thromb Vasc Biol 23 e61 e44 10.1161/01.ATV.0000101191.92392.1D
82. SM Boekholdt WR Agema RJ Peters AH Zwinderman EE van der Wall 2003 REgression GRowth Evaluation Statin Study Group. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events Circulation 107 2416 2421 10.1161/01.CIR.0000068311.40161.28
83. IA Yang JW Holloway S Ye 2003 Southampton Atherosclerosis Study (SAS) Group. TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis Atherosclerosis 170 187 190 10.1016/S0021-9150(03)00286-7
84. K Edfeldt AM Bennet P Eriksson J Frostegård B Wiman A Hamsten GK Hansson U de Faire ZQ Yan 2004 Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction Eur Heart J 25 1447 1453 10.1016/j.ehj.2004.05.004
85. PE Morange L Tiret N Saut G Luc D Arveiler J Ferrieres 2004 PRIME Study Group. TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and therisk of coronary heart disease: the PRIME study Eur J Hum Genet 12 1041 1049 10.1038/sj.ejhg.5201277
86. JW Holloway IA Yang S Ye 2005 Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction Pharmacogenet Genomics 15 15 21 10.1097/01213011-200501000-00003 (Pubitemid 43205522)
87. RY Zee HH Hegener J Gould PM Ridker 2005 Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis Stroke 36 154 157 10.1161/01.STR.0000149948.31879.f0
88. W Koch P Hoppmann A Pfeufer A Schömig A Kastrati 2006 Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population Eur Heart J 27 2524 2529 10.1093/eurheartj/ehl231
89. DF Terry M Wilcox MA [tmp] McCormick E Lawler TT Perls 2003 Cardiovascular advantages among the offspring of centenarians J Gerontol A Biol Sci Med Sci 58 M425 M431
90. DF Terry MA Wilcox MA McCormick JY Pennington EA Schoenhofen SL Andersen 2004 Lower all-cause, cardiovascular, and cancer mortality in centenarians' offspring Am Geriatr Soc 52 2074 2076 10.1111/j.1532-5415.2004.52561.x
91. D Lio G Candore A Crivello L Scola G Colonna-Romano L Cavallone 2004 Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease J Med Genet 41 790 794 10.1136/jmg.2004.019885
92. MP Grimaldi G Candore S Vasto M Caruso G Caimi E Hoffmann 2006 Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population J Leukoc Biol 79 611 615 10.1189/jlb.0705416
93. F Listì G Candore CR Balistreri M Caruso E Incalcaterra E Hoffmann 2007 Connexin37 1019 gene polymorphism in myocardial infarction patients and centenarians Atherosclerosis 191 460 461 10.1016/j.atherosclerosis.2006.08.009
94. F Listì G Candore MP Grimaldi D Lio G Colonna-Romano V Orlando 2007 Alpha1-antitrypsin heterozygosity plays a positive role in attainment of longevity Biogerontology 8 139 145 10.1007/s10522-006-9041-y
95. D Nuzzo S Vasto CR Balistreri D Di-Carlo F Listì G Caimi 2006 Role of proinflammatory alleles in longevity and atherosclerosis: results of studies performed on -1562C/T MMP-9 in centenarians and myocardial infarction patients from Sicily Ann N Y Acad Sci 1089 496 501 10.1196/annals.1386.048
96. F Listì C Caruso CR Balistreri MP Grimaldi M Caruso G Caimi 2007 PECAM-1/CD31 in infarction and longevity Ann N Y Acad Sci 1100 132 139 10.1196/annals.1395.011
97. CR Balistreri G Candore M Caruso E Incalcaterra C Franceschi C Caruso 2008 Role of polymorphisms of CC-chemokine receptor-5 gene in acute myocardial infarction and biological implications for longevity Haematologica 93 637 638 10.3324/haematol.12239
98. F Listì M Caruso E Incalcaterra E Hoffmann G Caimi CR Balistreri S Vasto V Scafidi C Caruso G Candore 2008 Pro-inflammatory gene variants in myocardial infarction and longevity: implications for pharmacogenomics Curr Pharm Des 14 2678 2685 10.2174/138161208786264115
99. CR Balistreri G Candore G Colonna-Romano D Lio M Caruso E Hoffmann 2004 Role of Toll-like receptor 4 in acute myocardial infarction and longevity JAMA 292 2339 2340 10.1001/jama.292.19.2339
100. A Nebel F Flachsbart A Schäfer M Nothnagel S Nikolaus NE Mokhtari S Schreiber 2007 Role of the toll-like receptor 4 polymorphism Asp299Gly in longevity and myocardial infarction in German men Mech Ageing Dev 128 409 411 10.1016/j.mad.2007.04.001
101. F Barzi M Woodward RM Marfisi L Tavazzi F Valagussa R Marchioli 2003 GISSI-Prevenzione Investigators. Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial Eur J Clin Nutr 57 604 611 10.1038/sj.ejcn.1601575
102. F Licastro G Candore D Lio E Porcellini G Colonna-Romano C Franceschi 2005 Caruso C. Innate immunity and inflammation in ageing: a key for understanding age-related diseases Immun Ageing 2 8 10.1186/1742-4933-2-8
103. NW Schroder RR Schumann 2005 Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease Lancet Infect Dis 5 156 164 10.1016/S1473-3099(05)01308-3